Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

R. Keers; R. Uher; P. Huezo-Diaz; R. Smith; S. Jaffee; M. Rietschel; N. Henigsberg; D. Kozel; O. Mors; W. Maier; A. Zobel; J. Hauser; D. Souery; A. Placentino; E. R. Larsen; M. Dmitrzak-Weglarz; B. Gupta; F. Hoda; I. Craig; P. McGuffin; A. E. Farmer; K. J. Aitchison

doi:10.1038/tpj.2010.14

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

R. Keers, R. Uher, P. Huezo-Diaz, R. Smith, S. Jaffee, M. Rietschel, N. Henigsberg, D. Kozel, O. Mors, W. Maier, A. Zobel, J. Hauser, D. Souery, A. Placentino, E. R. Larsen, M. Dmitrzak-Weglarz, B. Gupta, F. Hoda, I. Craig, P. McGuffinA. E. Farmer, K. J. Aitchison

Résultat de recherche: Article › examen par les pairs

73 Citations (Scopus)

Résumé

There is substantial inter-individual variation in response to antidepressants, and genetic variation may, in part, explain these differences. For example, there is evidence to suggest that variation in the serotonin transporter gene (SLC6A4) predicts response to selective serotonin reuptake inhibitors (SSRIs). Environmental factors such as the occurrence of stressful life events before treatment may also be important. One prior report suggests that both factors interact in predicting response to antidepressants. GENDEP, a prospective part-randomized pharmacogenomics trial, collected longitudinal data on the outcome of 811 patients with major depression undergoing treatment with either an SSRI (escitalopram) or a tricyclic antidepressant (nortriptyline). Life events experienced over 6 months preceding treatment were measured using a List of Threatening Experiences Questionnaire, and several polymorphisms in the serotonin transporter gene (SLC6A4) have been genotyped including the serotonin transporter-linked polymorphic region (5-HTTLPR). Stressful life events were shown to predict a significantly better response to escitalopram but had no effect on response to nortriptyline. Variation in the 5-HTTLPR and another polymorphism in the gene, STin4, significantly modified these effects. Gene-environment interactions including life events may therefore be important not only in the aetiology of depression, but also in predicting response to antidepressant medication.

Langue d'origine	English
Pages (de-à)	138-145
Nombre de pages	8
Journal	Pharmacogenomics Journal
Volume	11
Numéro de publication	2
DOI	https://doi.org/10.1038/tpj.2010.14
Statut de publication	Published - avr. 2011
Publié à l'externe	Oui

Note bibliographique

Funding Information:
We acknowledge the contribution of the following collaborators: Helen Dean, Amanda Elkin, Joanna Gray, Cerisse Gunasinghe, Desmond Campbell, David Dempster, Richard J Williamson, Caterina Giovannini, Julien Mendlewicz, Thomas Schulze, Jana Strohmaier, Christine Schmäl, Susanne Höfels, Anna Schuhmacher, Ute Pfeiffer, Sandra Weber, Anne Schinkel Stamp, Piotr Czerski Alenka Tancic, Jerneja Sveticic, Zrnka Kovacic, Pawe" Kapelski, Maria Skibińska, Aleksandra Rajewska, Aleksandra Szczepankiewicz and Elzbieta Cegielska. We specially acknowledge the contribution of Jorge Perez, who was the Principal Investigator at Brescia, Italy, and who passed away in October 2007, and the late Professor Andrej Marusic, who was the Lead Investigator at Ljubljana, and who passed away in June 2008. The GENDEP project was funded by the European Commission Framework 6 Grant, EC Contract Ref.: LSHB-CT-2003–503428. Lundbeck provided both nortriptyline and escitalopram free of charge for the GENDEP study. GlaxoSmithKline, the Medical Research Council, the Biomedical Research Center for Mental Health at the Institute of Psychiatry and South London and Maudsley NHS Foundation Trust (funded by the United Kingdom National Institute for Health Research of the Department of Health) contributed to the funding of the sample collection at the Institute of Psychiatry, London, through add-on projects or latterly staff funding. The sponsors had no role in the design and conduct of the study, in data collection, analysis, interpretation or writing the paper.

ASJC Scopus Subject Areas

Molecular Medicine
Genetics
Pharmacology

Accès au document

10.1038/tpj.2010.14

Autres fichiers et liens

Citer

Keers, R., Uher, R., Huezo-Diaz, P., Smith, R., Jaffee, S., Rietschel, M., Henigsberg, N., Kozel, D., Mors, O., Maier, W., Zobel, A., Hauser, J., Souery, D., Placentino, A., Larsen, E. R., Dmitrzak-Weglarz, M., Gupta, B., Hoda, F., Craig, I., ... Aitchison, K. J. (2011). Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenomics Journal, 11(2), 138-145. https://doi.org/10.1038/tpj.2010.14

Keers, R, Uher, R, Huezo-Diaz, P, Smith, R, Jaffee, S, Rietschel, M, Henigsberg, N, Kozel, D, Mors, O, Maier, W, Zobel, A, Hauser, J, Souery, D, Placentino, A, Larsen, ER, Dmitrzak-Weglarz, M, Gupta, B, Hoda, F, Craig, I, McGuffin, P, Farmer, AE & Aitchison, KJ 2011, 'Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project', Pharmacogenomics Journal, vol. 11, n° 2, pp. 138-145. https://doi.org/10.1038/tpj.2010.14

@article{2f646be774e84216a5d4e06566524628,

title = "Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project",

abstract = "There is substantial inter-individual variation in response to antidepressants, and genetic variation may, in part, explain these differences. For example, there is evidence to suggest that variation in the serotonin transporter gene (SLC6A4) predicts response to selective serotonin reuptake inhibitors (SSRIs). Environmental factors such as the occurrence of stressful life events before treatment may also be important. One prior report suggests that both factors interact in predicting response to antidepressants. GENDEP, a prospective part-randomized pharmacogenomics trial, collected longitudinal data on the outcome of 811 patients with major depression undergoing treatment with either an SSRI (escitalopram) or a tricyclic antidepressant (nortriptyline). Life events experienced over 6 months preceding treatment were measured using a List of Threatening Experiences Questionnaire, and several polymorphisms in the serotonin transporter gene (SLC6A4) have been genotyped including the serotonin transporter-linked polymorphic region (5-HTTLPR). Stressful life events were shown to predict a significantly better response to escitalopram but had no effect on response to nortriptyline. Variation in the 5-HTTLPR and another polymorphism in the gene, STin4, significantly modified these effects. Gene-environment interactions including life events may therefore be important not only in the aetiology of depression, but also in predicting response to antidepressant medication.",

author = "R. Keers and R. Uher and P. Huezo-Diaz and R. Smith and S. Jaffee and M. Rietschel and N. Henigsberg and D. Kozel and O. Mors and W. Maier and A. Zobel and J. Hauser and D. Souery and A. Placentino and Larsen, {E. R.} and M. Dmitrzak-Weglarz and B. Gupta and F. Hoda and I. Craig and P. McGuffin and Farmer, {A. E.} and Aitchison, {K. J.}",

note = "Funding Information: We acknowledge the contribution of the following collaborators: Helen Dean, Amanda Elkin, Joanna Gray, Cerisse Gunasinghe, Desmond Campbell, David Dempster, Richard J Williamson, Caterina Giovannini, Julien Mendlewicz, Thomas Schulze, Jana Strohmaier, Christine Schm{\"a}l, Susanne H{\"o}fels, Anna Schuhmacher, Ute Pfeiffer, Sandra Weber, Anne Schinkel Stamp, Piotr Czerski Alenka Tancic, Jerneja Sveticic, Zrnka Kovacic, Pawe{"} Kapelski, Maria Skibi{\'n}ska, Aleksandra Rajewska, Aleksandra Szczepankiewicz and Elzbieta Cegielska. We specially acknowledge the contribution of Jorge Perez, who was the Principal Investigator at Brescia, Italy, and who passed away in October 2007, and the late Professor Andrej Marusic, who was the Lead Investigator at Ljubljana, and who passed away in June 2008. The GENDEP project was funded by the European Commission Framework 6 Grant, EC Contract Ref.: LSHB-CT-2003–503428. Lundbeck provided both nortriptyline and escitalopram free of charge for the GENDEP study. GlaxoSmithKline, the Medical Research Council, the Biomedical Research Center for Mental Health at the Institute of Psychiatry and South London and Maudsley NHS Foundation Trust (funded by the United Kingdom National Institute for Health Research of the Department of Health) contributed to the funding of the sample collection at the Institute of Psychiatry, London, through add-on projects or latterly staff funding. The sponsors had no role in the design and conduct of the study, in data collection, analysis, interpretation or writing the paper.",

year = "2011",

month = apr,

doi = "10.1038/tpj.2010.14",

language = "English",

volume = "11",

pages = "138--145",

journal = "Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

AU - Keers, R.

AU - Uher, R.

AU - Huezo-Diaz, P.

AU - Smith, R.

AU - Jaffee, S.

AU - Rietschel, M.

AU - Henigsberg, N.

AU - Kozel, D.

AU - Mors, O.

AU - Maier, W.

AU - Zobel, A.

AU - Hauser, J.

AU - Souery, D.

AU - Placentino, A.

AU - Larsen, E. R.

AU - Dmitrzak-Weglarz, M.

AU - Gupta, B.

AU - Hoda, F.

AU - Craig, I.

AU - McGuffin, P.

AU - Farmer, A. E.

AU - Aitchison, K. J.

N1 - Funding Information: We acknowledge the contribution of the following collaborators: Helen Dean, Amanda Elkin, Joanna Gray, Cerisse Gunasinghe, Desmond Campbell, David Dempster, Richard J Williamson, Caterina Giovannini, Julien Mendlewicz, Thomas Schulze, Jana Strohmaier, Christine Schmäl, Susanne Höfels, Anna Schuhmacher, Ute Pfeiffer, Sandra Weber, Anne Schinkel Stamp, Piotr Czerski Alenka Tancic, Jerneja Sveticic, Zrnka Kovacic, Pawe" Kapelski, Maria Skibińska, Aleksandra Rajewska, Aleksandra Szczepankiewicz and Elzbieta Cegielska. We specially acknowledge the contribution of Jorge Perez, who was the Principal Investigator at Brescia, Italy, and who passed away in October 2007, and the late Professor Andrej Marusic, who was the Lead Investigator at Ljubljana, and who passed away in June 2008. The GENDEP project was funded by the European Commission Framework 6 Grant, EC Contract Ref.: LSHB-CT-2003–503428. Lundbeck provided both nortriptyline and escitalopram free of charge for the GENDEP study. GlaxoSmithKline, the Medical Research Council, the Biomedical Research Center for Mental Health at the Institute of Psychiatry and South London and Maudsley NHS Foundation Trust (funded by the United Kingdom National Institute for Health Research of the Department of Health) contributed to the funding of the sample collection at the Institute of Psychiatry, London, through add-on projects or latterly staff funding. The sponsors had no role in the design and conduct of the study, in data collection, analysis, interpretation or writing the paper.

PY - 2011/4

Y1 - 2011/4

N2 - There is substantial inter-individual variation in response to antidepressants, and genetic variation may, in part, explain these differences. For example, there is evidence to suggest that variation in the serotonin transporter gene (SLC6A4) predicts response to selective serotonin reuptake inhibitors (SSRIs). Environmental factors such as the occurrence of stressful life events before treatment may also be important. One prior report suggests that both factors interact in predicting response to antidepressants. GENDEP, a prospective part-randomized pharmacogenomics trial, collected longitudinal data on the outcome of 811 patients with major depression undergoing treatment with either an SSRI (escitalopram) or a tricyclic antidepressant (nortriptyline). Life events experienced over 6 months preceding treatment were measured using a List of Threatening Experiences Questionnaire, and several polymorphisms in the serotonin transporter gene (SLC6A4) have been genotyped including the serotonin transporter-linked polymorphic region (5-HTTLPR). Stressful life events were shown to predict a significantly better response to escitalopram but had no effect on response to nortriptyline. Variation in the 5-HTTLPR and another polymorphism in the gene, STin4, significantly modified these effects. Gene-environment interactions including life events may therefore be important not only in the aetiology of depression, but also in predicting response to antidepressant medication.

AB - There is substantial inter-individual variation in response to antidepressants, and genetic variation may, in part, explain these differences. For example, there is evidence to suggest that variation in the serotonin transporter gene (SLC6A4) predicts response to selective serotonin reuptake inhibitors (SSRIs). Environmental factors such as the occurrence of stressful life events before treatment may also be important. One prior report suggests that both factors interact in predicting response to antidepressants. GENDEP, a prospective part-randomized pharmacogenomics trial, collected longitudinal data on the outcome of 811 patients with major depression undergoing treatment with either an SSRI (escitalopram) or a tricyclic antidepressant (nortriptyline). Life events experienced over 6 months preceding treatment were measured using a List of Threatening Experiences Questionnaire, and several polymorphisms in the serotonin transporter gene (SLC6A4) have been genotyped including the serotonin transporter-linked polymorphic region (5-HTTLPR). Stressful life events were shown to predict a significantly better response to escitalopram but had no effect on response to nortriptyline. Variation in the 5-HTTLPR and another polymorphism in the gene, STin4, significantly modified these effects. Gene-environment interactions including life events may therefore be important not only in the aetiology of depression, but also in predicting response to antidepressant medication.

UR - http://www.scopus.com/inward/record.url?scp=79953042396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953042396&partnerID=8YFLogxK

U2 - 10.1038/tpj.2010.14

DO - 10.1038/tpj.2010.14

M3 - Article

C2 - 20212518

AN - SCOPUS:79953042396

SN - 1470-269X

VL - 11

SP - 138

EP - 145

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

IS - 2

ER -

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project

Résumé

Note bibliographique

ASJC Scopus Subject Areas

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer